Leadership & Pay ·
Oragenics, Inc. announced the appointment of John Spencer as Chief Financial Officer, effective July 1, 2026
OGENOragenics Inc
Oragenics, Inc. announced the appointment of John Spencer as Chief Financial Officer, effective July 1, 2026. Spencer, previously the company's Senior Controller, will receive a base compensation of $200,000 and a $25,000 option award. Additionally, at the annual meeting held on June 29, 2026, shareholders approved a proposal authorizing the Board of Directors to enact a reverse stock split at any time within one year, with a ratio between 1-for-2 and 1-for-50. The meeting also resulted in the re-election of six directors and the ratification of Cherry Bekaert LLP as independent auditors. Oragenics, Inc. is a biotechnology company.